Gordon K, Warren R, Gottlieb A, Blauvelt A, Thaci D, Leonardi C, Poulin Y, Boehnlein M, Kavanagh S, Arendt C, Reich K. Certolizumab Pegol for Treatment of Plaque Psoriasis: Pooled Three-Year Efficacy Outcomes from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2). J of Skin [Internet]. 2019Nov.9 [cited 2024Jul.3];3:S37. Available from: https://jofskin.org/index.php/skin/article/view/764